For systemic or injectable use, interaction data is nonexistent, and the risk assessment defaults to the broader concerns already discussed: unverified purity, uncontrolled dosing, and absent human trials
A lack of education and resources, taken alongside a generally lower level of baseline strength in older females compared to males, may deter females from initiating participation in RT programs and further promote the age-related loss in muscle and physical independence that disproportionately affects older females (de Jong et al., 2023)
10.1016/s0753-3322(03)00043-x Biomed Pharmacother
CJC-1295 & Ipamorelin Stimulate natural growth hormone release to promote recovery, fat loss, and muscle growth
(PubMed) Pereira MA, Grubbs CJ, Barnes LH, et al